IGFBP2衍生肽JB2促进神经可塑性并改善Phelan-McDermid综合征小鼠模型缺陷
研究开发了IGFBP2模拟肽片段JB2,在培养神经元和小鼠中验证其促进突触结构与功能可塑性;JB2直接结合树突和突触,依赖NMDA受体激活、基因转录翻译及IGF2受体而非IGF1受体。在Shank3杂合小鼠中,JB2改善了突触功能与可塑性、学习记忆、超声发声、运动功能,并使神经元兴奋性和癫痫易感性正常化,还改善了听诱发反应潜伏期、α峰频率和稳态脑电反应等具有人类转化价值的指标。
要点
- JB2直接结合树突和突触,依赖NMDA受体、基因转录翻译及IGF2受体,不依赖IGF1受体。
- 在Shank3杂合小鼠中JB2改善突触功能与可塑性、学习记忆、超声发声和运动缺陷。
- JB2使神经元兴奋性和癫痫易感性正常化,并改善听诱发反应潜伏期等转化指标。
核心结论
- JB2是有效的神经可塑性调节剂,对Phelan-McDermid综合征和孤独症谱系障碍具有治疗潜力。
研究设计与样本
- 在培养神经元和小鼠中研究IGFBP2模拟肽片段JB2的突触结合与可塑性效应。
- 在Shank3杂合小鼠模型中评估JB2对疾病相关表型的挽救作用。
主要发现
- JB2直接结合树突和突触,其生物活性涉及NMDA受体激活、基因转录和翻译以及IGF2受体,不依赖IGF1受体。
- JB2诱导神经元膜磷酸化蛋白质组广泛重塑,突触与细胞骨架调控、孤独症谱系障碍风险因素及Shank3相关蛋白网络在磷酸化与去磷酸化蛋白中显著富集。
- 在Shank3杂合小鼠中,JB2挽救了突触功能与可塑性、学习记忆、超声发声和运动功能缺陷。
- JB2使Shank3杂合小鼠的神经元兴奋性和癫痫易感性正常化。
- JB2挽救了听诱发反应潜伏期、α峰频率和稳态脑电图反应缺陷,这些指标对人类受试者具有直接转化价值。
临床怎么用
- JB2作为神经可塑性调节剂,为Phelan-McDermid综合征和孤独症谱系障碍的靶向治疗提供了临床前候选分子。
- 听诱发反应潜伏期、α峰频率和稳态脑电图反应等指标可作为JB2类神经可塑性调节剂从动物向人类转化的潜在生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We developed an IGFBP2-mimetic peptide fragment, JB2, and showed that it promotes basal synaptic structural and functional plasticity in cultured neurons and mice. We demonstrate that JB2 directly binds to dendrites and synapses, and its biological activity involves NMDA receptor activation, gene transcription and translation, and IGF2 receptors. It is not IGF1 receptor-dependent. In neurons, JB2 induced extensive remodeling of the membrane phosphoproteome. Synapse and cytoskeletal regulation, autism spectrum disorder (ASD) risk factors, and a Shank3-associated protein network were significantly enriched among phosphorylated and dephosphorylated proteins. Haploinsufficiency of the SHANK3 gene on chromosome 22q13.3 often causes Phelan-McDermid Syndrome (PMS), a genetically defined form of autism with profound deficits in motor behavior, sensory processing, language, and cognitive function. We identified multiple disease-relevant phenotypes in a Shank3 heterozygous mouse and showed that JB2 rescued deficits in synaptic function and plasticity, learning and memory, ultrasonic vocalizations, and motor function; it also normalized neuronal excitability and seizure susceptibility. Notably, JB2 rescued deficits in the auditory evoked response latency, alpha peak frequency, and steady-state electroencephalography response, measures with direct translational value to human subjects. These data demonstrate that JB2 is a potent modulator of neuroplasticity with therapeutic potential for the treatment of PMS and ASD.
引用
- Burgdorf JS, Yoon S, Dos Santos M, et al. An IGFBP2-derived peptide promotes neuroplasticity and rescues deficits in a mouse model of Phelan-McDermid syndrome. Mol Psychiatry. 2022. PMID: 36481930. doi:10.1038/s41380-022-01904-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。